HI
PASG icon

Harbour Investments’s Passage Bio PASG Stock Holding History

Harbour Investments’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15 Hold
3
– – ﹤0.01% 4731
2026
Q1 		$24 Hold
3
– – ﹤0.01% 4615
2025
Q4 		$35 Hold
3
– – ﹤0.01% 3805
2025
Q3 		$24 Buy
+3
New +$21 ﹤0.01% 3705
2025
Q2 		– Sell
-3
Closed -$21 – 3692
2025
Q1 		$21 Hold
3
– – ﹤0.01% 3522
2024
Q4 		$34 Hold
3
– – ﹤0.01% 3449
2024
Q3 		$42 Hold
3
– – ﹤0.01% 3351
2024
Q2 		$48 Buy
+3
New +$73 ﹤0.01% 3240

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Harbour Investments's PASG Position: Q2 2026 in Review

Harbour Investments held its Passage Bio (PASG) position steady in Q2 2026 at 3 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #4731.

Harbour Investments first reported a position in PASG in Q2 2024 and has held it in 8 quarters since. The position peaked at $48 in Q2 2024. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Harbour Investments held 3 shares of Passage Bio worth $15 as of Q2 2026.
  • Harbour Investments left its Passage Bio share count unchanged in Q2 2026.
  • Passage Bio made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4731 holding.
  • Harbour Investments first reported a position in Passage Bio in Q2 2024 and has held it in 8 quarters since.
  • Harbour Investments's Passage Bio position peaked at $48 in Q2 2024.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.